Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(0.25) per share from the same period last year.
Microsoft To Rally Around 27%? Here Are 10 Other Analyst Forecasts For Wednesday
Credit Suisse boosted the price target for Microsoft Corp (NASDAQ: MSFT) from $350 to $420. Credit Suisse analyst Sami Badri maintained the stock with an Outperform rating. Microsoft shares fell 0.5% to close at $331.21 on Tuesday.